This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Europe

ONLINE REGISTRATION CLOSES IN:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
Delivered as a Hybrid Event, 7 - 9 June, 2022
Live In-Person Event: 7 - 9 June, Postillion Hotel AmsterdamDigital Experience: All Sessions Livestreamed 7 - 9 June

Vladimir Tolmachev, Ph.D.
Professor, Department of Immunology, Genetics at Uppsala University

Profile

1984: Degree of Master of Science in Engineering, D. Mendeleyev Russian University of Chemical Technology. Moscow, Russia

1998, PhD in Medical Sciences: Uppsala University, Uppsala, Sweden

2003 Associate Professor in Biomedical Radiation Sciences, Uppsala University, Uppsala, Sweden

2005-2009 Senior Scientics, Affibody AB, Bromma, Sweden

2009 Senior Lecturer, Department of Radiology, Oncology and Radiation Sciences, Uppsala University, Uppsala, Sweden

2012-  Professor, Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden

2019- Head of Oncotheranostics Centre, Tomsk Polytechnic University, Tomsk. Russia

Published 297 papers, H-index 52

Agenda Sessions

  • Radionuclide Molecular Targeting of Cancer Using Engineered Scaffold Proteins

    10:50